Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer-Reference-Cited by-同舟云学术

Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer

Published:2019-04-19 Issue:4 Volume:2 Page:e192589
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Caram Megan E. V.¹²³,Ross Ryan⁴,Lin Paul³,Mukherjee Bhramar⁴

Affiliation:

1. Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor

2. Veterans Affairs (VA) Health Services Research and Development, Center for Clinical Management and Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan

3. Institute for Healthcare Policy and Innovation, University of Michigan Medical School, Ann Arbor

4. Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jamanetworkopen/article-pdf/2/4/e192589/17478505/caram_2019_oi_190113.pdf

Reference31 articles.

1. Sipuleucel-T immunotherapy for castration-resistant prostate cancer.;Kantoff;N Engl J Med,2010

2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.;Tannock;N Engl J Med,2004

3. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.;de Bono;Lancet,2010

4. Abiraterone and increased survival in metastatic prostate cancer.;de Bono;N Engl J Med,2011

5. Increased survival with enzalutamide in prostate cancer after chemotherapy.;Scher;N Engl J Med,2012

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial disparity in prostate cancer: an outlook in genetic and molecular landscape;Cancer and Metastasis Reviews;2024-06-20

2. Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study;JU Open Plus;2024-02-29

3. Racial disparity in the utilization of immunotherapy for advanced prostate cancer;Journal of the National Medical Association;2023-12

4. Cancer Cell Membrane Nanodiscs for Antitumor Vaccination;Nano Letters;2023-08-21

5. An inverse probability weighted regression method that accounts for right‐censoring for causal inference with multiple treatments and a binary outcome;Statistics in Medicine;2023-07